Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease

Stanley I. Rapoport, Kimmo Hatanpää, Daniel R. Brady, Krish Chandrasekaran

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Reduced brain glucose utilization in early stages of Alzheimer disease, as measured with in vivo positron emission tomography, reflects potentially reversible down-regulation of gene expression for oxidative phosphorylation within neuronal mitochondria. Such down-regulation may occur when neuronal energy demand is first reduced by synaptic dysfunction or loss.

Original languageEnglish (US)
Pages (from-to)473-476
Number of pages4
JournalNeurodegeneration
Volume5
Issue number4
DOIs
StatePublished - Dec 1996

Fingerprint

Oxidative Phosphorylation
Cognition
Energy Metabolism
Alzheimer Disease
Down-Regulation
Brain
Gene Expression Regulation
Positron-Emission Tomography
Mitochondria
Glucose

Keywords

  • Alzheimer disease
  • Brain
  • Energy metabolism
  • Mitochondria
  • Oxidative phosphorylation
  • Positron emission tomography

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Pathology and Forensic Medicine
  • Clinical Neurology

Cite this

Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease. / Rapoport, Stanley I.; Hatanpää, Kimmo; Brady, Daniel R.; Chandrasekaran, Krish.

In: Neurodegeneration, Vol. 5, No. 4, 12.1996, p. 473-476.

Research output: Contribution to journalArticle

Rapoport, Stanley I. ; Hatanpää, Kimmo ; Brady, Daniel R. ; Chandrasekaran, Krish. / Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease. In: Neurodegeneration. 1996 ; Vol. 5, No. 4. pp. 473-476.
@article{ecfd2fcc4aca45e099b5ead787a3560a,
title = "Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease",
abstract = "Reduced brain glucose utilization in early stages of Alzheimer disease, as measured with in vivo positron emission tomography, reflects potentially reversible down-regulation of gene expression for oxidative phosphorylation within neuronal mitochondria. Such down-regulation may occur when neuronal energy demand is first reduced by synaptic dysfunction or loss.",
keywords = "Alzheimer disease, Brain, Energy metabolism, Mitochondria, Oxidative phosphorylation, Positron emission tomography",
author = "Rapoport, {Stanley I.} and Kimmo Hatanp{\"a}{\"a} and Brady, {Daniel R.} and Krish Chandrasekaran",
year = "1996",
month = "12",
doi = "10.1006/neur.1996.0065",
language = "English (US)",
volume = "5",
pages = "473--476",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease

AU - Rapoport, Stanley I.

AU - Hatanpää, Kimmo

AU - Brady, Daniel R.

AU - Chandrasekaran, Krish

PY - 1996/12

Y1 - 1996/12

N2 - Reduced brain glucose utilization in early stages of Alzheimer disease, as measured with in vivo positron emission tomography, reflects potentially reversible down-regulation of gene expression for oxidative phosphorylation within neuronal mitochondria. Such down-regulation may occur when neuronal energy demand is first reduced by synaptic dysfunction or loss.

AB - Reduced brain glucose utilization in early stages of Alzheimer disease, as measured with in vivo positron emission tomography, reflects potentially reversible down-regulation of gene expression for oxidative phosphorylation within neuronal mitochondria. Such down-regulation may occur when neuronal energy demand is first reduced by synaptic dysfunction or loss.

KW - Alzheimer disease

KW - Brain

KW - Energy metabolism

KW - Mitochondria

KW - Oxidative phosphorylation

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=0030498070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030498070&partnerID=8YFLogxK

U2 - 10.1006/neur.1996.0065

DO - 10.1006/neur.1996.0065

M3 - Article

VL - 5

SP - 473

EP - 476

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 4

ER -